Search all trials

Find therapies in clinical trials near you – page 126

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Bms-986288

Contact Research Centre

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Registered drugNo placebo

Spain

Participants:65+ years
Substances:Anakinra

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

InvestigationalNo placebo

Study of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Patritumab Deruxtecan

Contact Research Centre

K-ras gene mutation

Not recruiting

Registered drugNo placebo

Study of BMS-986466 with Adagrasib and Cetuximab for Patients with KRAS G12C-mutant Advanced Solid Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Adagrasib

Contact Research Centre

Lung disorder

Not recruiting

Registered drug

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Baricitinib

Contact Research Centre

Lung disorder

Not recruiting

Investigational

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Bemcentinib

Contact Research Centre

Monkeypox

Not recruiting

Registered drugNo placebo

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Registered drugNo placebo

Spain

Participants:0–17 years · 18–64 years · 65+ years
Substances:Tecovirimat

Contact Research Centre

Transitional cell carcinoma

Not recruiting

Registered drug

Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

Registered drug

Spain

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

IgA nephropathy

Not recruiting

Investigational

Study on Sibeprenlimab for Patients with IgA Nephropathy

Investigational

Spain

Participants:18–64 years · 65+ years
Substances:Sibeprenlimab

Contact Research Centre

Gastrointestinal stromal tumour

Not recruiting

Registered drugNo placebo

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Sunitinib

Contact Research Centre

Squamous cell carcinoma of head and neck+2

Not recruiting

InvestigationalNo placebo

Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Lbl-007

Contact Research Centre

Find therapies in clinical trials near you – page 126

1 637 trials match your criteria

Non-small cell lung cancer

Study Comparing SB27 and Pembrolizumab for Patients with Metastatic Non-Small Cell Lung Cancer

Neoplasm

Study of BMS-986288 and Nivolumab for Patients with Advanced Solid Tumors

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Study on the Effectiveness and Safety of Epcoritamab Alone or with Lenalidomide for Patients with Diffuse Large B-Cell Lymphoma Who Cannot Use Anthracyclines

Hormone receptor positive HER2 negative breast cancer

Study of Patritumab Deruxtecan with or without Endocrine Therapy for High-Risk HR+/HER2- Early Breast Cancer in Untreated Patients

K-ras gene mutation

Study of BMS-986466 with Adagrasib and Cetuximab for Patients with KRAS G12C-mutant Advanced Solid Tumors

Lung disorder

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Lung disorder

Study on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19

Monkeypox

Study on Monkeypox Virus Disease: Effects of Tecovirimat in Patients with and without Antiviral Treatment

Transitional cell carcinoma

Study Comparing Nivolumab to Placebo for Patients with High-Risk Invasive Bladder Cancer

IgA nephropathy

Study on Sibeprenlimab for Patients with IgA Nephropathy

Gastrointestinal stromal tumour

Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

Squamous cell carcinoma of head and neck+2

Study of BGB-A425, LBL-007, and Tislelizumab for Patients with Advanced Head and Neck Cancer, Lung Cancer, or Kidney Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.